FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
Apr 22, 2022
Austin (Texas) [US], April 22 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the...